Madame Bioscience Public Company Limited (GLOCON.BK)
Bangkok, BKK, TH
Madame Bioscience Public Company Limited, together with its subsidiaries, engages in the food business in Thailand. It operates through Packaging Business, Retail Sales of Cosmetics, Food Business, and Other Business segments. The company offers various food products, including frozen processed and ready-to-eat food, chilled food, plant-based food, hemp food, processed food, and sauces under the Kitchen Plus and Look Chin Tip brands. It also provides flexible packaging, polyethylene terephthalate bottles, and food packaging trays for packaged food and beverages. In addition, the company engages in the manufacture and sale of plastic packaging, seafood, and processed meat; retail sale of cosmetics; advertising rental services in gas stations; restaurant business; network marketing; and trading activities. The company was formerly known as Global Consumer Public Company Limited and changed its name to Madame Bioscience Public Company Limited in July 2025. Madame Bioscience Public Company Limited was founded in 1987 and is headquartered in Bangkok, Thailand.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.35% | +2.13% | -14.29% | -18.64% | +182.35% | +242.86% | +200.00% | +6.67% | -20.00% | -20.00% | -20.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaging & Containers: +2.6%-30.4% Q1'26: +15.4% (vs Q1'25)
-
EPS growth Packaging & Containers: +8.0%+153.8% ★ Q1'26: -59.9% (vs Q1'25)
-
FCF margin FCF growth · Packaging & Containers: +34.6%-10.3% Q1'26: -8.3% (vs Q1'25)
-
EBIT margin Packaging & Containers: +7.0%-14.4% Q1'26: +5.2% (vs Q1'25)
-
ROIC Packaging & Containers: +6.2%-27.3% Q1'26: +8.5% (vs Q1'25)
-
Share dilution Packaging & Containers: +0.2%-75.1% ★ Q1'26: -76.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaging & Containers: 0.83×-1.21× Q1'26: 1.98× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-21 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-20 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-19 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-15 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-05 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chirdsak Kukiattinun | Executive Director | — | male |
| Kallayanee Kamolvisit | Chief Executive Officer | — | female |
| Kasem Paibulsirichit | Chief Financial Officer | — | male |
| Ramesh Kanapathy | Executive Director | — | male |
| Thititham Kamolvisit | Chief Operating Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GLOCON.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
